Skip to main content
OpenTrials

Clinical trial condition

Epilepsy, Generalized

Explore clinical trials studying Epilepsy, Generalized. Study availability and eligibility vary by location and protocol.

131 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Epilepsy, Generalized trial results

Completed

A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

NCT05218655

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +36 more
Locations
  • University of California, San Diego Altman Clinical and Translational Research Institute La Jolla, California, United States
  • Stanford University Stanford, California, United States
  • Yale Medicine New Haven, Connecticut, United States
  • Children's National Washington D.C., District of Columbia, United States
View all 26 locations
View Trial Details
Completed

Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy

NCT05626634

Conditions
Brain Diseases, CDKL5 deficiency disorder, Central Nervous System Diseases, +23 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Rancho Los Amigos National Rehabilitation Center (RLANRC) Downey, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Northwest Florida Clinical Research Group Gulf Breeze, Florida, United States
View all 28 locations
View Trial Details
Completed

A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome

NCT03936777

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Ep0215 107 Tucson, Arizona, United States
  • Ep0215 144 Los Angeles, California, United States
  • Ep0215 108 San Diego, California, United States
  • Ep0215 101 San Francisco, California, United States
View all 71 locations
View Trial Details
Completed

A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

NCT05109234

Conditions
Brain Diseases, Central Nervous System Diseases, Childhood Absence Epilepsy, +6 more
Locations
  • Ep0132 115 Birmingham, Alabama, United States
  • Ep0132 105 Orange, California, United States
  • Ep0132 110 Augusta, Georgia, United States
  • Ep0132 100 New Brunswick, New Jersey, United States
View all 24 locations
View Trial Details
Completed

An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome

NCT02823145

Conditions
Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +9 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Center for Neurosciences - Tucson Tucson, Arizona, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Rady Children's Hospital San Diego San Diego, California, United States
View all 67 locations
View Trial Details

Related conditions